Latest articles
Calm, cited readings of material exchange filings. Cited, not tips.
Sort:Newest
Sector:Healthcare
INDRAMEDCO · Indraprastha Medical Corporation Limited · NSE · Filed 6 Aug · 1 min
Apollo Delhi operator posts higher Q1 FY27 revenue and profit, sets AGM and dividend record date
Indraprastha Medical reported higher unaudited revenue and profit after tax for the June quarter and set a 24 September AGM with an 18 September dividend record date.
AUROPHARMA · Aurobindo Pharma Limited · NSE · Filed 5 Aug · 2 min
Aurobindo Pharma consolidates Lannett for the first time in Q1 FY27
The quarter ended June 30, 2026 is the first to include newly acquired US business Lannett Company LLC, which the company says makes results non-comparable to prior periods.
AUROPHARMA · Aurobindo Pharma Limited · BSE · Filed 5 Aug · 1 min
Aurobindo Pharma Q1 FY27 revenue up 16.3%, led by Europe and Growth Markets
Aurobindo reported consolidated Q1 FY27 revenue of ₹9,150 crore and net profit of ₹1,032 crore, with growth across formulations and API.
FERMENTA · Fermenta Biotech Limited · BSE · Filed 4 Aug · 1 min
Fermenta Biotech Sets 11 August Board Meeting for Q1 Results
Its board will meet on 11 August 2026 to approve unaudited standalone and consolidated results for the quarter ended 30 June 2026.
YATHARTH · Yatharth Hospital & Trauma Care Services Limited · BSE · Filed 4 Aug · 1 min
Yatharth Hospital board to weigh Q1 results, first interim dividend and 2026 ESOP scheme on 10 August
The hospital operator's board meets on 10 August 2026 to consider first-quarter results, a first interim dividend for FY2026-27, and a new employee stock option scheme.
BYKE · The Byke Hospitality Ltd · BSE · Filed 3 Aug · 1 min
Byke Hospitality to Consider Q1 FY27 Results on 10 August
The hotel operator's board meets on 10 August 2026 to approve unaudited results for the quarter ended 30 June 2026 and adopt the auditor's limited review report.
SUNPHARMA · Sun Pharmaceutical Industries Limited · NSE · Filed 31 Jul · 2 min
Sun Pharma Q1 FY27: sales up 10.1%, Organon deal cleared by target's shareholders
Consolidated sales and net profit both rose year-on-year, even as US generics slipped and the pending Organon acquisition began flowing costs through exceptional items.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · NSE · Filed 29 Jul · 1 min
Jagsonpal lifts Q1 FY27 profit, completes 85% buy of hospital-supplies firm Aequitas
The pharma company reported higher revenue and profit for the quarter ended June 2026 and closed an all-cash 85% acquisition of Aequitas Healthcare, its entry into hospital supplies.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · NSE · Filed 29 Jul · 2 min
Jagsonpal Q1 FY27 profit rises; discloses Aequitas stake buy and buy-back
The pharma company reported higher year-on-year quarterly net profit and disclosed an 85% stake acquisition and a share buy-back tied to the same period.
INDRAMEDCO · Indraprastha Medical Corporation Limited · BSE · Filed 27 Jul · 1 min
Indraprastha Medical Sets 6 August Board Meeting for Q1 Results
The Apollo hospital operator's board will meet on Thursday, 6 August 2026, to approve unaudited results for the quarter ended 30 June 2026.
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · BSE · Filed 22 Jul · 1 min
Jagsonpal Pharmaceuticals sets 29 July board meeting for Q1 results
The board meets on Wednesday, 29 July 2026 to approve unaudited results for the quarter ended 30 June 2026.
SUNPHARMA · Sun Pharmaceutical Industries Limited · BSE · Filed 10 Jul · 1 min
Sun Pharma to Report Q1 FY2027 Results on 31 July
The board meets that day to approve unaudited standalone and consolidated results for the quarter ended 30 June 2026.